Acutus Medical Inc

NASDAQ:AFIB  
0.79
-0.06 (-7.38%)
Officer Changes, Earnings Announcements

Acutus Medical Reports Q1 2022 Results And CEO Transition

Published: 05/12/2022 21:05 GMT
Acutus Medical Inc (AFIB) - Acutus Medical Reports First Quarter 2022 Financial Results and CEO Transition.
Q1 Revenue $3.7 Million.
Vince Burgess Stepping Down As Company's President and Chief Executive Officer.
Appoints David Roman As Interim Chief Executive Officer and Chief Financial Officer.
Q1 Loss per Share $1.42.
Q1 Non-GAAP Loss per Share $1.00 Excluding Items.
Q1 Earnings per Share View $-0.92, Revenue View $3.1 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $3.78 Million
Adjusted EPS is expected to be -$0.80

Next Quarter Revenue Guidance is expected to be $4.31 Million
Next Quarter EPS Guidance is expected to be -$0.74

More details on our Analysts Page.